Page last updated: 2024-10-24

cetyltrimethylammonium ion and Atrophy

cetyltrimethylammonium ion has been researched along with Atrophy in 1 studies

Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research Excerpts

ExcerptRelevanceReference
"40 nm) was significantly decreased in rats with villous atrophy and crypt hypoplasia induced by the cytostatic agent methotrexate."3.66Passive permeability in experimental intestinal damage in rats. ( Axon, AT; Cobden, I; Rothwell, J, 1981)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cobden, I1
Rothwell, J1
Axon, AT1

Other Studies

1 other study available for cetyltrimethylammonium ion and Atrophy

ArticleYear
Passive permeability in experimental intestinal damage in rats.
    Clinical science (London, England : 1979), 1981, Volume: 60, Issue:1

    Topics: Animals; Atrophy; Cetrimonium; Cetrimonium Compounds; Intestinal Absorption; Intestinal Mucosa; Lact

1981